X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (207) 207
humans (196) 196
oncology (156) 156
male (118) 118
cancer (96) 96
female (89) 89
middle aged (75) 75
aged (74) 74
urology & nephrology (72) 72
antineoplastic agents - therapeutic use (68) 68
metastasis (63) 63
carcinoma, renal cell - drug therapy (57) 57
treatment outcome (56) 56
kidney neoplasms - drug therapy (55) 55
article (54) 54
urology (52) 52
kidney neoplasms - pathology (51) 51
survival (51) 51
sunitinib (49) 49
carcinoma, renal cell (47) 47
care and treatment (43) 43
everolimus (42) 42
renal cell carcinoma (40) 40
adult (37) 37
animals (37) 37
immunotherapy (36) 36
aged, 80 and over (35) 35
prostate cancer (35) 35
targeted therapy (35) 35
chemotherapy (34) 34
carcinoma, renal cell - pathology (33) 33
retrospective studies (31) 31
therapy (31) 31
interferon-alpha (30) 30
disease-free survival (28) 28
patients (27) 27
prognosis (27) 27
trial (26) 26
antineoplastic combined chemotherapy protocols - therapeutic use (25) 25
metastases (25) 25
neoplasm metastasis (25) 25
analysis (24) 24
carcinoma, renal cell - secondary (24) 24
hematology, oncology and palliative medicine (24) 24
research (23) 23
sorafenib (23) 23
carcinoma, renal cell - genetics (22) 22
carcinoma, renal cell - mortality (22) 22
clear cell-type renal cell carcinoma (21) 21
clinical trials as topic (21) 21
drug therapy (21) 21
expression (21) 21
kidney neoplasms - mortality (21) 21
molecular targeted therapy (21) 21
docetaxel (20) 20
health aspects (20) 20
phase-iii trial (20) 20
prostatic neoplasms - pathology (20) 20
survival analysis (20) 20
mice (19) 19
carcinoma (18) 18
metastatic renal cell carcinoma (18) 18
mutation (18) 18
open-label (18) 18
protein kinase inhibitors - therapeutic use (18) 18
vascular endothelial growth factor (18) 18
antibodies, monoclonal - therapeutic use (17) 17
antineoplastic agents - pharmacology (17) 17
bevacizumab (17) 17
bladder cancer (17) 17
kaplan-meier estimate (17) 17
patient outcomes (17) 17
pazopanib (17) 17
urothelial carcinoma (17) 17
biomarkers (16) 16
immunology (16) 16
kidney cancer (16) 16
kidney neoplasms - genetics (16) 16
multicenter (16) 16
neoplasm staging (16) 16
studies (16) 16
abiraterone (15) 15
abridged index medicus (15) 15
breast cancer (15) 15
cisplatin (15) 15
nivolumab (15) 15
tumors (15) 15
angiogenesis (14) 14
clinical trials (14) 14
combination (14) 14
prostatic neoplasms - drug therapy (14) 14
stat3 (14) 14
temsirolimus (14) 14
internal medicine (13) 13
medicine & public health (13) 13
pharmacology & pharmacy (13) 13
pyrimidines - therapeutic use (13) 13
urinary bladder neoplasms - drug therapy (13) 13
urinary bladder neoplasms - pathology (13) 13
biochemistry & molecular biology (12) 12
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


European urology, ISSN 0302-2838, 07/2019
Journal Article
Nature Reviews Urology, ISSN 1759-4812, 2018, Volume 15, Issue 9, pp. 530 - 532
Cytoreductive nephrectomy, a standard approach for de novo metastatic renal cell carcinoma in the era of cytokine therapy, has been upheld during the age of... 
UROLOGY & NEPHROLOGY | CANCER | RENAL-CELL CARCINOMA | Usage | Care and treatment | Nephrectomy | Analysis | Oncology, Experimental | Carcinoma, Renal cell | Metastasis | Research | Cancer
Journal Article
Urologic Oncology: Seminars and Original Investigations, ISSN 1078-1439, 2018
Renal cell carcinoma (RCC) is a commonly diagnosed and histologically diverse urologic malignancy. Clear cell RCC (ccRCC) is by far the most common, followed... 
Molecular profiling | Molecular genetics | Genetic mutations | Renal cell carcinoma | Targeted therapy
Journal Article
Nature Reviews Clinical Oncology, ISSN 1759-4774, 2014, Volume 11, Issue 9, pp. 504 - 506
Journal Article
Cancer, ISSN 0008-543X, 06/2014, Volume 120, Issue 11, pp. 1604 - 1607
Journal Article
Molecular oncology, ISSN 1574-7891, 09/2019
The androgen receptor (AR) plays key roles in the development of prostate tissue and the development and progression of prostate cancer (PC). AR guides... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2016, Volume 34, Issue 2_suppl, pp. 293 - 293
Journal Article
Cancer, ISSN 0008-543X, 09/2015, Volume 121, Issue 18, pp. 3190 - 3192
Journal Article
Urologic Oncology: Seminars and Original Investigations, ISSN 1078-1439, 2017, Volume 35, Issue 5, pp. 180 - 182
The role of cytoreductive nephrectomy (CN) was firmly established in the cytokine era on the basis of 2 randomized studies employing adjunctive interferon... 
Urology | Cytoreductive nephrectomy | Cytokines | Targeted therapy | Immunotherapy
Journal Article
Cancer, ISSN 0008-543X, 09/2015, Volume 121, Issue 18, pp. 3190 - 3192
The enumeration of circulating tumor cells has established prognostic value in patients with metastatic castration‐resistant prostate cancer. Herein, the... 
RESISTANCE | MCRPC PATIENTS | AR-V7 | ONCOLOGY | ENZALUTAMIDE | ABIRATERONE | Prostatic Neoplasms - pathology | Neoplastic Cells, Circulating - classification | Neoplastic Cells, Circulating - pathology | Cell Nucleus - pathology | Neoplasm Metastasis - pathology | Humans | Male
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2016, Volume 34, Issue 15_suppl, pp. e16021 - e16021
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2016, Volume 34, Issue 2_suppl, pp. 187 - 187
Journal Article
Future Oncology, ISSN 1479-6694, 08/2015, Volume 11, Issue 15, pp. 2137 - 2148
PROSTVAC immunotherapy is a heterologous prime-boost regimen of two different recombinant pox-virus vectors; vaccinia as the primary immunotherapy, followed by... 
Journal Article
Urology Case Reports, ISSN 2214-4420, 07/2018, Volume 19, pp. 60 - 62
Journal Article
Cancer, ISSN 0008-543X, 06/2014, Volume 120, Issue 11, pp. 1604 - 1607
The current editorial focuses on a phase 2 study evaluating ramucirumab in patients with metastatic renal cell carcinoma (mRCC) who have received prior... 
Vascular Endothelial Growth Factor Receptor-2 - antagonists & inhibitors | Protein Kinase Inhibitors - therapeutic use | Humans | Antibodies, Monoclonal - therapeutic use | Female | Male | Carcinoma, Renal Cell - drug therapy | Kidney Neoplasms - drug therapy
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.